Finding 520905 (2024-006)

Significant Deficiency
Requirement
N
Questioned Costs
-
Year
2024
Accepted
2025-01-31
Audit: 340797
Organization: Wheeling Jesuit University INC (WV)
Auditor: Bdo USA PC

AI Summary

  • Core Issue: The University failed to refund Title IV credit balances to some students within the required 14-day timeframe.
  • Impacted Requirements: This non-compliance violates Title IV regulations (34 CFR 668.164(h)) regarding timely disbursement of student financial assistance.
  • Recommended Follow-Up: Enhance internal controls and procedures to ensure timely refunds and prevent future compliance issues.

Finding Text

Finding 2024-006 – N. Special Tests and Provisions – Disbursement to or on Behalf of Students – Credit Balances Information on Federal Program(s) – Student Financial Assistance Cluster (ALN’s 84.007, 84.063, 84.268, 84.379) Criteria or Specific Requirement – Title IV regulations (34 CFR 668.164(h)) require institutions to pay Title IV credit balances directly to the student or parent borrower within 14 days after (1) the first day of class of a payment period if the credit balance occurred on or before that day, or (2) the balance occurred if that was after the first day of class. Condition – The University did not refund credit balances to certain students within the required timeframe. Cause - Administrative oversight and insufficient internal controls. Effect or Potential Effect – The University was not in compliance with the federal guidelines over credit balances from student financial assistance. Questioned Costs – None. Context – 3 of 40 Title IV credit balances tested were not paid within the required timeframe. Indication of Repeat Finding - No similar findings noted in the prior year. Recommendation – We recommend the University enhance its procedures and internal controls to ensure that Title IV credit balances are paid to students timely. Views of Responsible Officials – The University acknowledges that we were not in compliance during fiscal year 2024 with the federal guidelines to refund the student credit balances in a timely manner for the students in question. There was significant employee turnover at the University in the business office during fiscal year 2024 and training of new employees was ongoing at that time. This resulted in the delay in the student refunds within the sample selection that the auditors chose during fiscal year 2024. Since then the new and current staff members have been fully trained on their duties and responsibilities. Everyone involved has been informed of the student refund policies and requirements per the Title IV regulations. There have been procedures implemented to prevent this from being a repeat audit finding in the future.

Corrective Action Plan

Name of Responsible Individual: Tracy Jenkins, Student Account Billing Coordinator Corrective Action: The University acknowledges that we were not in compliance during fiscal year 2024 with the federal guidelines to refund the student credit balances in a timely manner for the students in question. There was significant employee turnover at the University in the business office during fiscal year 2024 and training of new employees was ongoing at that time. This resulted in the delay in the student refunds within the sample selection that the auditors chose during fiscal year 2024. Since then the new and current staff members have been fully trained on their duties and responsibilities. Everyone involved has been informed of the student refund policies and requirements per the Title IV regulations. There have been procedures implemented to prevent this from being a repeat audit finding in the future. Anticipated Completion Date: July 2024

Categories

Internal Control / Segregation of Duties Special Tests & Provisions Student Financial Aid

Other Findings in this Audit

  • 520902 2024-011
    Material Weakness Repeat
  • 520903 2024-012
    Material Weakness
  • 520904 2024-005
    Significant Deficiency Repeat
  • 520906 2024-010
    Significant Deficiency Repeat
  • 520907 2024-007
    Significant Deficiency
  • 520908 2024-010
    Significant Deficiency Repeat
  • 520909 2024-009
    Significant Deficiency Repeat
  • 520910 2024-010
    Significant Deficiency Repeat
  • 520911 2024-002
    Significant Deficiency Repeat
  • 520912 2024-004
    Significant Deficiency Repeat
  • 520913 2024-005
    Significant Deficiency Repeat
  • 520914 2024-008
    Significant Deficiency
  • 520915 2024-010
    Significant Deficiency Repeat
  • 520916 2024-003
    Significant Deficiency Repeat
  • 520917 2024-004
    Significant Deficiency Repeat
  • 520918 2024-005
    Significant Deficiency Repeat
  • 520919 2024-006
    Significant Deficiency
  • 520920 2024-010
    Significant Deficiency Repeat
  • 520921 2024-005
    Significant Deficiency Repeat
  • 520922 2024-006
    Significant Deficiency
  • 520923 2024-010
    Significant Deficiency Repeat
  • 520924 2024-011
    Material Weakness Repeat
  • 1097344 2024-011
    Material Weakness Repeat
  • 1097345 2024-012
    Material Weakness
  • 1097346 2024-005
    Significant Deficiency Repeat
  • 1097347 2024-006
    Significant Deficiency
  • 1097348 2024-010
    Significant Deficiency Repeat
  • 1097349 2024-007
    Significant Deficiency
  • 1097350 2024-010
    Significant Deficiency Repeat
  • 1097351 2024-009
    Significant Deficiency Repeat
  • 1097352 2024-010
    Significant Deficiency Repeat
  • 1097353 2024-002
    Significant Deficiency Repeat
  • 1097354 2024-004
    Significant Deficiency Repeat
  • 1097355 2024-005
    Significant Deficiency Repeat
  • 1097356 2024-008
    Significant Deficiency
  • 1097357 2024-010
    Significant Deficiency Repeat
  • 1097358 2024-003
    Significant Deficiency Repeat
  • 1097359 2024-004
    Significant Deficiency Repeat
  • 1097360 2024-005
    Significant Deficiency Repeat
  • 1097361 2024-006
    Significant Deficiency
  • 1097362 2024-010
    Significant Deficiency Repeat
  • 1097363 2024-005
    Significant Deficiency Repeat
  • 1097364 2024-006
    Significant Deficiency
  • 1097365 2024-010
    Significant Deficiency Repeat
  • 1097366 2024-011
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
84.268 Federal Direct Student Loans $6.34M
84.063 Federal Pell Grant Program $1.19M
43.009 Mission Support $533,620
93.859 Biomedical Research and Research Training $249,046
84.007 Federal Supplemental Educational Opportunity Grants $173,481
84.033 Federal Work-Study Program $64,449
84.379 Teacher Education Assistance for College and Higher Education Grants (teach Grants) $7,544
84.038 Federal Perkins Loan Program $0